Zolmitriptan NDC 68462-497

NDC codes

FDA NDC Directory

Product NDC (as listed)68462-497Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68462-0497Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
68462-497-76	68462049776	1 BLISTER PACK in 1 CARTON (68462-497-76) / 6 TABLET, FILM COATED in 1 BLISTER PACK (68462-497-40)Marketed from May 14, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Zolmitriptan
Generic name (nonproprietary): zolmitriptan
Active ingredients: Zolmitriptan — 2.5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Glenmark Pharmaceuticals Inc.,USA
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201779
Marketing start: May 14, 2013
Listing expires: Dec 31, 2027
Other FDA classes: Serotonin 1b Receptor Agonists (Mechanism)Serotonin 1d Receptor Agonists (Mechanism)
Identifiers: Product ID 68462-497_742c4c1c-c601-4656-86c1-69021eb552c9SPL ID 742c4c1c-c601-4656-86c1-69021eb552c9SPL set ID 333caafc-2e63-49f8-a0c6-534e528d228dRxCUI 200193, 200194UNII 2FS66TH3YWUPC 0368462497760, 0368462498330
Pharmacologic class: Serotonin-1b and Serotonin-1d Receptor Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468462049776 followed by a unit qualifier and the quantity

Package 68462-0497-76. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 29, 2026.

Indications (excerpt from the label)

Zolmitriptan tablets are indicated for the acute treatment of migraine with or without aura in adults. Limitations of Use • Only use zolmitriptan tablets if a clear diagnosis of migraine has been established. If a patient has no response to zolmitriptan tablets treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan tablets are administered to treat any subsequent attacks. • Zolmitriptan tablets are not indicated for the prevention of migraine attacks. • Safety and effectiveness of zolmitriptan tablets have not been established for cluster headache. Zolmitriptan tablets are a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute t…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 201779

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201779
Product	Strength	Form · route	Labeler	Product NDC
Zolmitriptan	Zolmitriptan 5 mg/1	Tablet, Film coatedOral	Glenmark Pharmaceuticals Inc.,USA	68462-498
Zolmitriptan	Zolmitriptan 2.5 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-249
Zolmitriptan	Zolmitriptan 5 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-250